Business Wire26d
Verdiva Bio, a New Clinical-Stage Cardiometabolic Company, Launches with Over $410M in Series A Financing to Advance Next-Generation Therapies
Logos Capital, Lilly Asia Ventures, and LYFE Capital (collectively, “the Investor Group”). Khurem Farooq, formerly the CEO of Aiolos Bio and Gyroscope Therapeutics, will serve as Chief ...
pharmaphorum1y
JPM: GSK announces $1.4bn deal to buy asthma biotech Aiolos
GSK has taken another step towards rebuilding its respiratory pipeline with a $1.4 billion agreement to buy Aiolos Bio and its lead drug AIO-001 for asthma and other indications. The deal ...
BioSpace26d
Verdiva Bio, a New Clinical-Stage Cardiometabolic Company, Launches with Over $410M in Series A Financing to Advance Next-Generation Therapies
Logos Capital, Lilly Asia Ventures, and LYFE Capital (collectively, “the Investor Group”). Khurem Farooq, formerly the CEO of Aiolos Bio and Gyroscope Therapeutics, will serve as Chief Executive ...